Bank of America
IHE icon

Bank of America’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bank of America’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$6.57K – 8413
2024
Q4 		$6.57K Buy
+100
New +$6.88K ﹤0.01% 7054

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America's IHE Position: Q1 2026 in Review

Bank of America increased its iShares US Pharmaceuticals ETF (IHE) stake by 2.8% in Q1 2026, buying an estimated $1.1M and bringing the position to 456,606 shares worth $39.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Bank of America first reported a position in IHE in Q2 2013 and has held it in 52 quarters since. The position peaked at $44.7M in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Bank of America held 456,606 shares of iShares US Pharmaceuticals ETF worth $39.6M as of Q1 2026.
  • Bank of America bought 12,565 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $1.1M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1782 holding.
  • Bank of America first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's iShares US Pharmaceuticals ETF position peaked at $44.7M in Q2 2015.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.